scanX
Home
Nectar Lifesciences

Nectar Lifesciences

34.28
-0.70
(-2.00%)
Market Cap (₹ Cr.)
₹782
52 Week High
56.50
Book Value
₹
52 Week Low
26.15
PE Ratio
72.69
PB Ratio
0.73
PE for Sector
37.21
PB for Sector
3.95
ROE
%
ROCE
8.65 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
8.41 %
Net Income Growth
120.66 %
Cash Flow Change
68.12 %
ROE
120.57 %
ROCE
200.30 %
EBITDA Margin (Avg.)
59.32 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
436
409
398
399
476
356
416
446
449
319
435
533
595
534
724
733
800
582
572
653
561
389
428
379
350
390
370
444
477
403
399
357
407
395
409
453
443
360
429
Expenses
368
347
334
334
422
297
353
375
394
265
369
464
542
473
659
666
724
518
523
596
508
372
396
345
345
349
337
396
427
361
396
343
369
359
371
410
393
320
385
EBITDA
69
62
64
65
54
58
63
71
55
54
66
70
52
61
65
67
76
64
48
57
53
17
32
33
5
41
33
47
50
42
3
15
38
36
37
43
50
40
44
Operating Profit %
13 %
15 %
16 %
16 %
11 %
16 %
15 %
16 %
9 %
17 %
15 %
13 %
9 %
11 %
9 %
9 %
9 %
11 %
8 %
9 %
9 %
4 %
7 %
9 %
1 %
9 %
8 %
11 %
10 %
10 %
-2 %
0 %
5 %
9 %
7 %
9 %
11 %
11 %
10 %
Depreciation
19
15
16
16
10
15
15
15
17
15
17
16
16
16
16
17
15
16
14
15
15
15
15
15
15
14
14
14
14
15
15
15
15
15
15
15
15
15
16
Interest
27
27
31
30
35
29
29
34
26
27
28
31
30
30
44
36
39
31
33
31
31
28
28
31
26
26
18
18
17
21
21
17
20
18
21
25
24
20
20
Profit Before Tax
22
19
17
19
9
15
19
22
11
12
22
23
6
15
6
14
23
16
2
11
7
-26
-11
-12
-36
1
0
15
18
6
-32
-18
3
3
2
2
11
5
9
Tax
6
4
4
4
-2
2
3
4
3
1
4
4
-1
1
0
3
3
2
-1
1
-1
0
0
0
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
17
15
14
15
11
12
16
18
9
10
19
19
4
13
5
11
17
14
2
9
6
-17
-7
-8
-41
2
2
10
12
4
-22
-9
5
2
1
2
1
3
6
EPS in ₹
0.75
0.66
0.61
0.66
0.50
0.55
0.72
0.81
0.38
0.46
0.84
0.85
0.17
0.59
0.24
0.50
0.78
0.60
0.08
0.40
0.26
-0.75
-0.33
-0.36
-1.83
0.09
0.08
0.43
0.52
0.18
-1.00
-0.41
0.24
0.08
0.05
0.07
0.03
0.13
0.25
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2,510
2,557
2,581
2,724
2,704
2,632
2,387
2,390
2,189
2,191
Fixed Assets
934
906
881
852
825
785
772
723
662
643
Current Assets
1,369
1,464
1,496
1,660
1,667
1,614
1,238
1,354
1,231
1,284
Capital Work in Progress
91
99
102
100
100
115
99
85
78
66
Investments
0
1
1
1
1
1
1
1
1
1
Other Assets
1,485
1,551
1,597
1,771
1,778
1,732
1,515
1,580
1,449
1,482
Total Liabilities
1,553
1,602
1,574
1,665
1,599
1,498
1,326
1,303
1,125
1,122
Current Liabilities
1,156
1,240
1,279
1,309
1,299
1,248
1,187
1,004
891
973
Non Current Liabilities
397
362
296
356
300
250
139
299
234
149
Total Equity
958
954
1,007
1,059
1,105
1,135
1,061
1,087
1,065
1,069
Reserve & Surplus
936
932
984
1,036
1,082
1,112
1,038
1,064
1,042
1,047
Share Capital
22
22
22
22
22
22
22
22
22
22
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
23
3
-24
-4
12
1
4
-8
-0
2
Investing Activities
-60
-77
-18
-29
-26
-33
-29
17
52
-17
Operating Activities
144
169
199
65
239
286
21
95
133
225
Financing Activities
-61
-89
-204
-40
-201
-252
11
-119
-186
-205
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
55.80 %
FIIs
2.62 %
2.62 %
2.46 %
1.52 %
1.67 %
1.49 %
1.53 %
1.40 %
1.48 %
1.41 %
1.43 %
1.53 %
2.39 %
2.08 %
3.24 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
14.59 %
14.52 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
0.02 %
Public / Retail
41.58 %
41.58 %
41.74 %
42.68 %
42.53 %
42.72 %
28.06 %
28.19 %
28.11 %
28.18 %
28.16 %
28.06 %
27.21 %
27.57 %
40.94 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,770.00 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,461.60 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,522.90 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,193.90 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
943.40 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,037.90 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,219.25 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,591.10 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,464.00 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,569.80 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
41.44
ATR(14)
Less Volatile
1.54
STOCH(9,6)
Neutral
25.16
STOCH RSI(14)
Neutral
43.89
MACD(12,26)
Bullish
0.01
ADX(14)
Weak Trend
22.24
UO(9)
Bearish
40.05
ROC(12)
Downtrend And Accelerating
-2.64
WillR(14)
Neutral
-69.72
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.